We develop research tools and
molecular diagnostic products to advance epigenetics
and fulfill the promise of personalized medicine.
Qiagen to market MethylScreen™ Kits for research use under a
Orion and Novartis collaborate to discover and develop novel
Orion engaged in consortium with the Malaysian Palm Oil Board
to study epigenetic underpinnings of desirable traits in
two species of oil palm.
MethylScope® technology enables genome-wide DNA methylation
profiling, allowing the identification of DNA biomarkers
important to epigenetic studies.
MethylScreen technology validates putative epigenetics
biomarkers and precisely identifies epigenetics biomarkers in sample.
» More News